Primary Biliary Cholangitis
Cross-source consensus on Primary Biliary Cholangitis from 1 sources and 3 claims.
1 sources · 3 claims
Risks & contraindications
Other
Highlighted claims
- Primary biliary cholangitis is a rare chronic cholestatic liver disease with unmet need despite current therapy. — Optimising Primary thErapy in pRimAry biliary cholangitis (OPERA): protocol for a randomised, double-blind, placebo-controlled trial of enhanced primary therapy with obeticholic acid
- PBC can progress to cirrhosis and cause symptoms such as pruritus, fatigue, and cognitive dysfunction. — Optimising Primary thErapy in pRimAry biliary cholangitis (OPERA): protocol for a randomised, double-blind, placebo-controlled trial of enhanced primary therapy with obeticholic acid
- More than 80% of treated patients continue to experience symptoms, especially fatigue and cognitive symptoms. — Optimising Primary thErapy in pRimAry biliary cholangitis (OPERA): protocol for a randomised, double-blind, placebo-controlled trial of enhanced primary therapy with obeticholic acid